Fig 4. Example of nAMD disease progression on OCT from pre-lockdow to follow-up visit in the delayed and non-delayed groups.

A-B. A representative patient with nAMD presented pre-lockdown visit (A) with controlled nAMD. The patient returned for a 6 week follow up with stable disease (B). C-D. Another patient with nAMD presented for pre-lockdown visit with stable disease (C) with a plan for follow-up in 4 weeks. Follow-up was delayed by 6 weeks and OCT revealed significant accumulation of subretinal fluid.